Palbociclib extends progression-free survival in advanced breast cancer patients
Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer patients, including those whose disease has stopped responding to traditional endocrine treatments.
More... |
Re: Palbociclib extends progression-free survival in advanced breast cancer patients
I read some info on Palbociclib (Ibrance) and condensded the common side effects with a "nonsense word."
Fanthappal-epi-UTI Fatigue, anemia, neutropenia, throbocytopenia (Fanth) appetite decrease, alopecia (usually not severe) = appal epistaxis (nosebleed) and Upper respiratory infections =Epi-UTI Perhaps this might be useful Paul |
All times are GMT -7. The time now is 04:05 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021